CN101868156B - 含瓜氨酸的饮料 - Google Patents
含瓜氨酸的饮料 Download PDFInfo
- Publication number
- CN101868156B CN101868156B CN200880116481.5A CN200880116481A CN101868156B CN 101868156 B CN101868156 B CN 101868156B CN 200880116481 A CN200880116481 A CN 200880116481A CN 101868156 B CN101868156 B CN 101868156B
- Authority
- CN
- China
- Prior art keywords
- beverage
- citrulling
- citric acid
- acid
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 title abstract 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002173 citrulline Drugs 0.000 title abstract 3
- 235000013477 citrulline Nutrition 0.000 title abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 93
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 18
- 235000013361 beverage Nutrition 0.000 claims description 43
- 235000019800 disodium phosphate Nutrition 0.000 claims description 17
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 17
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 17
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 description 16
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 12
- 230000001877 deodorizing effect Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- -1 slaine Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000576 food coloring agent Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000006229 amino acid addition Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000360590 Erythrites Species 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 159000000013 aluminium salts Chemical class 0.000 description 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
需要开发一种含瓜氨酸的便于饮用的饮料，其中抑制了因储存或加热而产生的恶臭。为此，本发明提供一种含有瓜氨酸和柠檬酸、以及柠檬酸钠或磷酸氢二钠的饮料。
Description
技术领域
本发明涉及含有瓜氨酸和柠檬酸、以及柠檬酸钠或磷酸氢二钠的饮料。
背景技术
瓜氨酸，不是构成活生物体中蛋白质的氨基酸，而是尿素循环中的一种中间体，其由精氨酸与已知具有血管舒张作用的物质一氧化氮(NO)产生，并且与天冬氨酸缩合而再生为精氨酸。已知瓜氨酸表现出有益的作用如促进氨代谢(非专利文献1)、通过血管舒张而改善血流(非专利文献2)、降低血压(非专利文献3)、神经传递(非专利文献4)、免疫增强(非专利文献5)、以及消除活性氧(专利文献1)。鉴于此，在期望这些作用的条件下，通常惯例是以药物、功能性食品等的形式摄入瓜氨酸。
已知在碱性氨基酸如赖氨酸、精氨酸、鸟氨酸、羟赖氨酸和组氨酸的水溶液中，由于储存或加热而产生恶臭，还已知，通过向所述水溶液中添加水溶性还原剂和螯合剂可抑制所述恶臭(专利文献2)。
专利文献1：JP-A-2002-226370
专列文献2：JP-A-5-246962
非专利文献1：Cell Biochemistry & Function(细胞生物化学与功能)，2003，vol.21，p.85-91
非专利文献2：European Journal of Pharmacology(欧洲药理学杂志)，2001，vol.431，p.61-69
非专利文献3：Journal of Clinical Investigation(临床研究杂志)，1991，vol.88，p.1559-1567
非专利文献4：Gastroenterology(胃肠学)，1997，vol.112，p.1250-1259
非专利文献5：The journal ob biological chemistry(生物学化学杂志)，1994，vol.269，p.9405-9408
发明内容
本发明要解决的问题
需要开发一种含瓜氨酸的便于饮用的饮料，其中因储存或加热而产生的恶臭受到抑制。
解决所述问题的手段
为了解决上述问题，本发明人进行了广泛的研究，发现通过使得在含瓜氨酸的饮料中存在柠檬酸和柠檬酸钠、或者柠檬酸和磷酸氢二钠，抑制了因储存或加热而产生恶臭，并完成了本发明。
因此，本发明涉及下列(1)～(5)。
(1)一种饮料，其含含瓜氨酸和柠檬酸、以及柠檬酸钠或磷酸氢二钠。
(2)如上述(1)所述的饮料，其中所述瓜氨酸的浓度为0.01～2wt％。
(3)如上述(1)或(2)所述的饮料，其中柠檬酸和柠檬酸钠的重量配比为5∶1～1∶6，柠檬酸和柠檬酸钠的合计浓度为0.01～3wt％。
(4)如上述(1)或(2)所述的饮料，其中柠檬酸和磷酸氢二钠的重量配比为3∶1～1∶5，柠檬酸和磷酸氢二钠的合计浓度为0.01～4wt％。
(5)如上述(1)～(4)中任一项所述的饮料，其中pH为2～7。
技术效果
根据本发明，可提供一种含瓜氨酸的便于饮用的饮料，其中抑制了因储存或加热而产生的恶臭。
具体实施方式
作为本发明中所使用的瓜氨酸，能够提及的有L-瓜氨酸和D-瓜氨酸，优选L-瓜氨酸。
通过基于化学合成的方法、基于发酵生产的方法等，能够获得瓜氨酸。通过市售产品也能够获得瓜氨酸。
作为化学合成瓜氨酸的方法的实例，能够提及的有在J.Biol.Chem.(生物化学杂志)122，477(1938)和J.Org.Chem.(有机化学杂志)6，410(1941)中所述的方法。
作为通过发酵来制造L-瓜氨酸的方法的实例，能够提及的有JP-A-SHO-53-075387和JP-A-SHO-63-068091中所述的方法。
从Sigma-Aldrich Corporation等也能采购L-瓜氨酸和D-瓜氨酸。
在本发明中，可使用瓜氨酸的盐来代替瓜氨酸。
作为瓜氨酸的盐，能够提及的有酸加成盐、金属盐、铵盐、有机胺加成盐、氨基酸加成盐等。
作为酸加成盐，能够提及的有无机酸盐如盐酸盐、硫酸盐、硝酸盐和磷酸盐；以及有机酸盐如乙酸盐、马来酸盐、富马酸盐、柠檬酸盐、苹果酸盐、乳酸盐、α-酮戊二酸盐、葡萄糖酸盐、辛酸盐、己二酸盐、琥珀酸盐、酒石酸盐和抗坏血酸盐。
作为金属盐，能够提及的有碱金属盐如钠盐和钾盐；碱土金属盐如镁盐和钙盐；铝盐；锌盐等。
作为铵盐，能够提及的有铵、四甲基铵等的盐。
作为有机胺加成盐，能够提及的有吗啉、吡啶等的盐。
作为氨基酸加成盐，能够提及的有甘氨酸、苯丙氨酸、赖氨酸、天冬氨酸、谷氨酸等的盐。
在上述瓜氨酸的盐中，优选使用柠檬酸盐和苹果酸盐；可以适当地以组合的方式使用其他盐或2种以上的盐。
除了含有瓜氨酸和柠檬酸、以及柠檬酸钠或磷酸氢二钠之外，本发明的饮料能够通过普通的饮料制造方法制造。
可以向本发明的饮料中补充糖类、酸味剂、防腐剂如抗氧化剂、着色剂、调味剂、以及在普通饮料中所使用的其他各种添加剂。为了期望提高健康功能，还可以添加维生素、矿物质和各种功能性成分。可以压入二氧化碳以得到碳酸饮料。
未对糖类进行特殊限制，只要它们可用于制造饮料即可；单糖、二糖、低聚糖、多糖、糖醇和甜味剂中的任意一种都是可以的。作为糖类的实例，能够提及的有葡萄糖、果糖、蔗糖、麦芽糖、海藻糖、木糖醇、赤藓醇、还原的葡萄糖浆、糊精、淀粉、山梨糖醇、麦芽糖醇、三氯蔗糖、阿斯巴甜、乙酰磺胺酸钾、甜菊、糖精钠、甘草酸二钾和索马甜，优选葡萄糖、果糖和蔗糖。
未对酸味剂进行特殊限制，只要它们可用于制造饮料即可；实例包括酒石酸和苹果酸。
未对抗氧化剂进行特殊限制，只要它们可用于饮料中即可；实例包括生育酚、抗坏血酸、盐酸半胱氨酸和L-抗坏血酸硬脂酸酯。
未对着色剂进行特殊限制，只要它们可用于饮料中即可；实例包括食用色素黄5号、食用色素红2号、食用色素蓝2号、类胡萝卜色素和番茄色素。
未对调味剂进行特殊限制，只要它们可用于饮料中即可；实例包括柠檬香料、柠檬-莱檬香料、葡萄柚香料和苹果香料。
本发明饮料的pH通常为2～7，优选3～7，尤其优选3～6；利用pH调节剂如有机酸和无机酸来调节饮料的pH。
未对有机酸和无机酸进行特殊限制，只要它们可用于生产饮料即可。作为有机酸和无机酸的代替，可使用它们的盐。未对有机酸和无机酸的盐进行特殊限制，只要它们可用于制造饮料即可。
在本发明饮料中所包含的瓜氨酸的浓度通常为0.01～2wt％，优选0.05～2wt％，更优选0.1～2wt％。
当在本发明饮料中使用柠檬酸钠时，在饮料中所包含的柠檬酸和柠檬酸钠的重量配比通常为5∶1～1∶6，优选4∶1～1∶5，更优选3∶1～1∶4。柠檬酸和柠檬酸钠的合计浓度通常为0.01～3wt％，优选0.05～2wt％，更优选0.1～1wt％。在前述情况中，饮料中柠檬酸离子的浓度通常为0.0078～2.9wt％，优选0.039～1.9wt％，更优选0.078～0.95wt％。
当将磷酸氢二钠用于本发明的饮料中时，饮料中所包含的柠檬酸与磷酸氢二钠的重量配比通常为3∶1～1∶5，优选2∶1～1∶4，更优选1∶1～1∶3。柠檬酸和磷酸氢二钠的合计浓度通常为0.01～4wt％，优选0.05～3wt％，更优选0.1～2wt％。
在本发明中，例如当使用瓜氨酸柠檬酸盐来代替瓜氨酸时，柠檬酸包括衍生自瓜氨酸柠檬酸盐的柠檬酸。
通过将瓜氨酸、柠檬酸、柠檬酸钠或磷酸氢二钠以前述浓度存在于饮料中，可提供一种便于饮用的饮料，其中抑制了因储存或加热而产生的恶臭。
下文中显示了试验例，其中对本发明含瓜氨酸饮料中抑制恶臭的效果进行了检测。
试验例1(柠檬酸和柠檬酸钠抑制恶臭的效果)
将实施例1和2以及比较例1中的各种饮料放入带盖的瓶子中并在120℃下加热20分钟，其后，由六名受试者进行感官评价试验。与比较例1中产生的恶臭相比较，使用如下评价标准来确定等级：1.有效除臭；2.轻度有效除臭；3.除臭效果很少；4.除臭无效。结果示于表1中。
表1 评价的平均值
实施例1 1.8
实施例2 1.3
由表1看出，含有柠檬酸和柠檬酸钠的实施例1和2的饮料，获得了明确的除臭效果。
试验例2(柠檬酸和磷酸氢二钠抑制恶臭的效果)
将实施例3和4以及比较例1中的各种饮料放入带盖的瓶子中并在120℃下加热20分钟，其后，由六名受试者进行感官评价试验。与比较例1中产生的恶臭相比较，使用如下评价标准来确定等级：1.有效除臭；2.轻度有效除臭；3.除臭效果很少；4.除臭无效。结果示于表2中。
表2 评价的平均值
实施例3 1.5
实施例4 1.4
由表2看出，含有柠檬酸和磷酸氢二钠的实施例3和4的饮料，获得了明确的除臭效果。
下文中显示了本发明的实施例。
实施例1
含瓜氨酸的饮料(1)
成分 量(g)
L-瓜氨酸(由协和发酵工业社制造) 1.00
柠檬酸(由Kishida化学社制造) 0.75
柠檬酸钠(由Kishida化学社制造) 0.25
将这些成分溶于超纯水中，使得总体积为100ml。
实施例2
含瓜氨酸的饮料(2)
成分 量(g)
L-瓜氨酸(由协和发酵工业社制造) 1.00
柠檬酸(由Kishida化学社制造) 0.20
柠檬酸钠(由Kishida化学社制造) 0.80
将这些成分溶于超纯水中，使得总体积为100ml。
实施例3
含瓜氨酸的饮料(3)
成分 量(g)
L-瓜氨酸(由协和发酵工业社制造) 1.00
柠檬酸(由Kishida化学社制造) 1.00
磷酸氢二钠(由和光纯药社制造) 1.00
将这些成分溶于超纯水中，使得总体积为100ml。
实施例4
含瓜氨酸的饮料(4)
成分 量(g)
L-瓜氨酸(由协和发酵工业社制造) 1.00
柠檬酸(由Kishida化学社制造) 0.50
磷酸氢二钠(由和光纯药社制造) 1.50
将这些成分溶于超纯水中，使得总体积为100ml。
比较例1
制备在超纯水中含1wt％L-瓜氨酸的饮料。
工业应用
根据本发明，可提供含瓜氨酸的便于饮用的饮料，其中抑制了因储存或加热而产生的恶臭。
Claims (3)
1.一种饮料，其含有瓜氨酸和柠檬酸，以及柠檬酸钠，
其中所述瓜氨酸的浓度为0.01～2wt%，以及
柠檬酸和柠檬酸钠的重量配比为5:1～1:6，柠檬酸和柠檬酸钠的合计浓度为0.01～3wt%。
2.一种饮料，其含有瓜氨酸和柠檬酸，以及磷酸氢二钠，
其中所述瓜氨酸的浓度为0.01～2wt%，以及
柠檬酸和磷酸氢二钠的重量配比为3:1～1:5，柠檬酸和磷酸氢二钠的合计浓度为0.01～4wt%。
3.如权利要求1或2所述的饮料，其中pH为2～7。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007297950 | 2007-11-16 | ||
| JP2007-297950 | 2007-11-16 | ||
| PCT/JP2008/070842 WO2009064004A1 (ja) | 2007-11-16 | 2008-11-17 | シトルリン含有飲料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101868156A CN101868156A (zh) | 2010-10-20 |
| CN101868156B true CN101868156B (zh) | 2014-03-12 |
Family
ID=40638849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880116481.5A Active CN101868156B (zh) | 2007-11-16 | 2008-11-17 | 含瓜氨酸的饮料 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8679568B2 (zh) |
| EP (1) | EP2215915B1 (zh) |
| JP (2) | JP5944091B2 (zh) |
| KR (1) | KR101547374B1 (zh) |
| CN (1) | CN101868156B (zh) |
| CA (1) | CA2706556A1 (zh) |
| WO (1) | WO2009064004A1 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4964793B2 (ja) * | 2008-01-22 | 2012-07-04 | アサヒ飲料株式会社 | シトルリン含有飲食品及びその製造方法 |
| NZ717599A (en) * | 2012-01-03 | 2017-05-26 | Nestec Sa | Compositions and methods for the stability of reactive amino acids in a food matrix |
| US11102994B2 (en) | 2014-08-21 | 2021-08-31 | Clearfast Inc. | Pre-operative carbohydrate-rich beverage composition and methods of treatment |
| JP6357625B2 (ja) * | 2015-07-23 | 2018-07-18 | テクノサイエンス株式会社 | 栄養補助食品用の組成物 |
| KR102396603B1 (ko) | 2015-09-16 | 2022-05-11 | 원광대학교산학협력단 | 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물 |
| JP6634397B2 (ja) * | 2016-02-10 | 2020-01-22 | 花王株式会社 | 容器詰飲料 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007039610A (ja) * | 2005-08-05 | 2007-02-15 | Asahi Breweries Ltd | レモンフレーバーの香気劣化抑制方法およびその飲料 |
| JP2007185113A (ja) * | 2006-01-11 | 2007-07-26 | Seiya Sakurai | コンニャク流動材料およびその製造方法と用途 |
| JP5246962B2 (ja) * | 2010-02-05 | 2013-07-24 | 典政 佐々木 | 地球の自転によるコリオリの力検証装置 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322407A (en) * | 1978-12-11 | 1982-03-30 | Vitapharm Pharmaceutical Pty. Ltd. | Electrolyte drink |
| JPS6283882A (ja) | 1985-10-04 | 1987-04-17 | Hitoshi Yoshida | 高麗人じん酢の製造方法 |
| JPH0673446B2 (ja) | 1986-08-15 | 1994-09-21 | 長野県 | 西瓜ワインの製造法 |
| US4946701A (en) * | 1989-08-04 | 1990-08-07 | Procter & Gamble | Beverages |
| US5411757A (en) * | 1989-11-09 | 1995-05-02 | Buist; Neil R. M. | Palatable balanced amino acid-modified diet |
| JPH05246962A (ja) | 1992-03-02 | 1993-09-24 | Ajinomoto Co Inc | 塩基性アミノ酸またはその塩を含む水溶液の防臭方法 |
| US6703056B2 (en) * | 2000-09-29 | 2004-03-09 | The Procter + Gamble Co. | Beverage compositions comprising arabinogalactan and defined minerals |
| JP3329799B2 (ja) * | 2000-11-17 | 2002-09-30 | 花王株式会社 | 容器詰飲料 |
| JP3843298B2 (ja) | 2001-02-05 | 2006-11-08 | 国立大学法人 奈良先端科学技術大学院大学 | シトルリンを含有する活性酸素消去剤 |
| US20030211133A1 (en) | 2002-05-10 | 2003-11-13 | Special Ops Nutrition, L.L.C. | Ingestible composition for enhancing athletic performance |
| JP2004173504A (ja) | 2002-11-22 | 2004-06-24 | Yakult Honsha Co Ltd | 飲料の沈殿防止方法 |
| WO2005105126A1 (ja) * | 2004-04-30 | 2005-11-10 | National University Corporation NARA Institute of Science and Technology | 野生種スイカ抽出物を含有する活性酸素消去剤ならびに保湿剤 |
| US7897192B2 (en) | 2004-10-07 | 2011-03-01 | Next Proteins, Inc. | High energy carbonated protein drink and method of making |
| JP4545632B2 (ja) | 2005-04-25 | 2010-09-15 | 株式会社 伊藤園 | 葉酸含有組成物及び葉酸の安定化方法 |
| EP1913943B1 (en) * | 2005-06-27 | 2011-09-21 | Kyowa Hakko Bio Co., Ltd. | Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| CN101247801B (zh) * | 2005-08-25 | 2012-08-22 | 协和发酵生化株式会社 | 血中酒精浓度上升抑制用组合物 |
| JP5697835B2 (ja) * | 2005-12-05 | 2015-04-08 | 協和発酵バイオ株式会社 | 皮膚の乾燥予防または改善用経口剤 |
| JP2007274933A (ja) | 2006-04-04 | 2007-10-25 | Ito En Ltd | ヒアルロン酸含有飲料及びその製造方法 |
| WO2007133642A1 (en) * | 2006-05-11 | 2007-11-22 | Garcia Ramon D | Sport drink containing amino acids and carbohydrates |
| JP4847829B2 (ja) * | 2006-09-25 | 2011-12-28 | 協和発酵バイオ株式会社 | 酢かど抑制方法 |
| WO2008105325A1 (ja) | 2007-02-23 | 2008-09-04 | Kyowa Hakko Bio Co., Ltd. | シトルリン含有飲料 |
-
2008
- 2008-11-17 CN CN200880116481.5A patent/CN101868156B/zh active Active
- 2008-11-17 EP EP08850028.5A patent/EP2215915B1/en active Active
- 2008-11-17 CA CA2706556A patent/CA2706556A1/en not_active Abandoned
- 2008-11-17 JP JP2009541200A patent/JP5944091B2/ja active Active
- 2008-11-17 WO PCT/JP2008/070842 patent/WO2009064004A1/ja active Application Filing
- 2008-11-17 US US12/743,172 patent/US8679568B2/en active Active
- 2008-11-17 KR KR1020107013197A patent/KR101547374B1/ko active IP Right Grant
-
2014
- 2014-02-07 US US14/175,698 patent/US9375479B2/en active Active
- 2014-08-12 JP JP2014164545A patent/JP5955358B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007039610A (ja) * | 2005-08-05 | 2007-02-15 | Asahi Breweries Ltd | レモンフレーバーの香気劣化抑制方法およびその飲料 |
| JP2007185113A (ja) * | 2006-01-11 | 2007-07-26 | Seiya Sakurai | コンニャク流動材料およびその製造方法と用途 |
| JP5246962B2 (ja) * | 2010-02-05 | 2013-07-24 | 典政 佐々木 | 地球の自転によるコリオリの力検証装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20100255174A1 (en) | 2010-10-07 |
| KR101547374B1 (ko) | 2015-08-25 |
| CN101868156A (zh) | 2010-10-20 |
| EP2215915A4 (en) | 2014-10-15 |
| JP2014236743A (ja) | 2014-12-18 |
| EP2215915A1 (en) | 2010-08-11 |
| US8679568B2 (en) | 2014-03-25 |
| JP5944091B2 (ja) | 2016-07-05 |
| EP2215915B1 (en) | 2017-04-05 |
| JP5955358B2 (ja) | 2016-07-20 |
| US20140179783A1 (en) | 2014-06-26 |
| CA2706556A1 (en) | 2009-05-22 |
| US9375479B2 (en) | 2016-06-28 |
| KR20100100878A (ko) | 2010-09-15 |
| JPWO2009064004A1 (ja) | 2011-03-31 |
| WO2009064004A1 (ja) | 2009-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101868156B (zh) | 含瓜氨酸的饮料 | |
| KR101283900B1 (ko) | 뒷맛을 감소시키거나 없애기 위한 스포츠 드링크 산 혼합물 | |
| JP2011120479A (ja) | 塩基性アミノ酸含有容器詰め飲料 | |
| TW201021721A (en) | Low-calorie beverage composition containing luo han guo extract and sucralose | |
| JP5534806B2 (ja) | シトルリン含有飲料 | |
| JP5162812B2 (ja) | 亜鉛含有経口投与用組成物 | |
| JP5586816B2 (ja) | 亜鉛化合物配合組成物 | |
| JP5098198B2 (ja) | 銅化合物配合組成物 | |
| JP4929628B2 (ja) | 亜鉛含有内服液剤 | |
| JP5721352B2 (ja) | ビタミン類含有飲料 | |
| JP5044957B2 (ja) | 銅化合物配合組成物 | |
| JP5167594B2 (ja) | 銅化合物配合内服液用組成物 | |
| TWI818031B (zh) | 飲料、飲料之製造方法或組合 | |
| JP5546089B2 (ja) | 亜鉛化合物配合組成物 | |
| JP5181486B2 (ja) | 亜鉛化合物配合経口用組成物 | |
| JP5011776B2 (ja) | 銅化合物配合組成物 | |
| JP2007246509A (ja) | 銅化合物配合経口用組成物 | |
| JP2008289438A (ja) | 液体調味料 | |
| JP2016005443A (ja) | 容器詰め飲料 | |
| JP2017200451A (ja) | 飲料 | |
| JP2019076045A (ja) | フルーティーなノンアルコールビール | |
| JPWO2017150715A1 (ja) | 飲料製品、ならびに飲料製品を製造するための方法および装置 | |
| JP2018014962A (ja) | 飲料 | |
| JP2006169178A (ja) | 銅含有経口投与用組成物 | |
| JP2017055691A (ja) | 飲料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |